July 13, 2026 · Form 4 insider transaction
Agarwal Arjun bought 8,541 shares of Oruka Therapeutics, Inc. at $12.50 per share, a transaction worth $106.8K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 0 days after the transaction.